Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 109
Filtrar
Más filtros













Intervalo de año de publicación
1.
Biotech Histochem ; 99(3): 125-133, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38533595

RESUMEN

The adipocyte-derived hormone, leptin, plays a key role in the maintenance of energy homeostasis. Leptin binds to the long form of its receptor, which is predominantly expressed in various hypothalamic regions, including the lateral hypothalamic area (LH) and supraoptic nucleus (SO). Several studies have suggested that leptin directly activates neuronal nitric oxide synthase, leading to increased nitric oxide production. We used histochemistry for nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) as a marker for nitric oxide synthase activity and assessed the effect of leptin on nitrergic neurons in the LH and SO of rats. We found that intraperitoneal administration of leptin led to a significant increase in the number of NADPH-d-positive neurons in the LH and SO. In addition, the intensity (optical density) of NADPH-d staining in LH and SO neurons was significantly elevated in rats that received leptin compared with saline-treated rats. These findings suggest that nitrergic neurons in the LH and SO may be implicated in mediating the central effects of leptin.


Asunto(s)
Área Hipotalámica Lateral , Leptina , Neuronas Nitrérgicas , Núcleo Supraóptico , Animales , Leptina/farmacología , Leptina/metabolismo , Masculino , Área Hipotalámica Lateral/efectos de los fármacos , Área Hipotalámica Lateral/metabolismo , Ratas , Núcleo Supraóptico/efectos de los fármacos , Núcleo Supraóptico/metabolismo , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/metabolismo , NADPH Deshidrogenasa/metabolismo , Ratas Wistar , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Ratas Sprague-Dawley
2.
Physiol Rep ; 9(4): e14752, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33600071

RESUMEN

Xenin25 has a variety of physiological functions in the Gastrointestinal (GI) tract, including ion transport and motility. However, the motility responses in the colon induced by Xenin25 remain poorly understood. Therefore, the effect of Xenin25 on the spontaneous circular muscle contractions of the rat distal colon was investigated using organ bath chambers and immunohistochemistry. Xenin25 induced the inhibition followed by postinhibitory spontaneous contractions with a higher frequency in the rat distal colon. This inhibitory effect of Xenin25 was significantly suppressed by TTX but not by atropine. The inhibitory time (the duration of inhibition) caused by Xenin25 was shortened by the NTSR1 antagonist SR48692, the NK1R antagonist CP96345, the VPAC2 receptor antagonist PG99-465, the nitric oxide-sensitive guanylate-cyclase inhibitor ODQ, and the Ca2+ -dependent K+ channel blocker apamin. The higher frequency of postinhibitory spontaneous contractions induced by Xenin25 was also attenuated by ODQ and apamin. SP-, NOS-, and VIP-immunoreactive neurons were detected in the myenteric plexus (MP) of the rat distal colon. Small subsets of the SP-positive neurons were also Calbindin positive. Most of the VIP-positive neurons were also NOS positive, and small subsets of the NK1R-positive neurons were also VIP positive. Based on the present results, we propose the following mechanism. Xenin25 activates neuronal NTSR1 on the SP neurons of IPANs, and transmitters from the VIP and apamin-sensitive NO neurons synergistically inhibit the spontaneous circular muscle contractions via NK1R. Subsequently, the postinhibitory spontaneous contractions are induced by the offset of apamin-sensitive NO neuron activation via the interstitial cells of Cajal. In addition, Xenin25 also activates the muscular NTSR1 to induce relaxation. Thus, Xenin25 is considered to be an important modulator of post prandial circular muscle contraction of distal colon since the release of Xenin25 from enteroendocrine cells is stimulated by food intake.


Asunto(s)
Colon/inervación , Sistema Nervioso Entérico/efectos de los fármacos , Fármacos Gastrointestinales/farmacología , Motilidad Gastrointestinal/efectos de los fármacos , Contracción Muscular/efectos de los fármacos , Músculo Esquelético/inervación , Neurotensina/farmacología , Animales , Sistema Nervioso Entérico/metabolismo , Técnicas In Vitro , Masculino , Inhibición Neural/efectos de los fármacos , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/metabolismo , Ratas Sprague-Dawley , Receptores de Neurotensina/metabolismo , Sustancia P/metabolismo , Péptido Intestinal Vasoactivo/metabolismo
3.
Int J Mol Sci ; 21(12)2020 Jun 26.
Artículo en Inglés | MEDLINE | ID: mdl-32604714

RESUMEN

Bisphenol A (BPA) is one of the most common environmental pollutants among endocrine disruptors. Due to its similarity to estrogen, BPA may affect estrogen receptors and show adverse effects on many internal organs. The reproductive system is particularly vulnerable to the impact of BPA, but knowledge about BPA-induced changes in the innervation of the uterus is relatively scarce. Therefore, this study aimed to investigate the influence of various doses of BPA on nitrergic nerves supplying the uterus with the double immunofluorescence method. It has been shown that even low doses of BPA caused an increase in the number of nitrergic nerves in the uterine wall and changed their neurochemical characterization. During the present study, changes in the number of nitrergic nerves simultaneously immunoreactive to substance P, vasoactive intestinal polypeptide, pituitary adenylate cyclase-activating peptide, and/or cocaine- and amphetamine-regulated transcript were found under the influence of BPA. The obtained results strongly suggest that nitrergic nerves in the uterine wall participate in adaptive and/or protective processes aimed at homeostasis maintenance in the uterine activity under the impact of BPA.


Asunto(s)
Compuestos de Bencidrilo/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Neuronas Nitrérgicas/fisiología , Fenoles/farmacología , Útero/fisiología , Animales , Disruptores Endocrinos/farmacología , Femenino , Neuronas Nitrérgicas/efectos de los fármacos , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/metabolismo , Sustancia P/metabolismo , Porcinos , Útero/química , Útero/efectos de los fármacos , Péptido Intestinal Vasoactivo/metabolismo
4.
Neurotoxicology ; 77: 193-204, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-32007490

RESUMEN

Given the well-known antioxidant and neuroprotective properties of quercetin, the aim of this work was to evaluate the effects of quercetin stabilized by microencapsulation at two doses (10 mg kg-1 and 100 mg kg-1) on the oxidative/antioxidant status, number and morphological features of ICC, nitrergic neurons and M2-like macrophages in jejunum of diabetic rats. The rats were randomly distributed into six groups: normoglycemic control (N), diabetic control (D) and either normoglycemic or diabetic groups treated with quercetin-loaded microcapsules at a dose of 10 mg kg-1 (NQ10 and DQ10, respectively) or 100 mg kg-1 (NQ100 and DQ100, respectively). After 60 days, the jejunum was collected. Whole mounts were immunostained for Ano1, nNOS and CD206, and oxidative stress levels and total antioxidant capacity of the jejunum were measured. Diabetes led to a loss of ICC and nitrergic neurons, but increased numbers of M2-like macrophages and elevated levels of oxidative stress were seen in diabetic animals. High-dose administration of quercetin (100 mg kg-1) further aggravated the diabetic condition (DQ100) but this treatment resulted in harmful effects on healthy rats (NQ100), pointing to a pro-oxidant activity. However, low-dose administration of quercetin (10 mg kg-1) gave rise to antioxidant and protective effects on ICC, nNOS, macrophages and oxidative/antioxidant status in DQ100, but NQ100 displayed infrequent negative outcomes in normoglycemic animals. Microencapsulation of the quercetin may become promising alternatives to reduce diabetes-induced oxidative stress but antioxidant therapies should be careful used under healthy status to avoid toxic effects.


Asunto(s)
Antioxidantes/administración & dosificación , Diabetes Mellitus Tipo 1/metabolismo , Yeyuno/efectos de los fármacos , Macrófagos/efectos de los fármacos , Neuronas Nitrérgicas/efectos de los fármacos , Quercetina/administración & dosificación , Telocitos/efectos de los fármacos , Animales , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/inducido químicamente , Composición de Medicamentos , Yeyuno/metabolismo , Macrófagos/metabolismo , Masculino , Plexo Mientérico/efectos de los fármacos , Plexo Mientérico/metabolismo , Neuronas Nitrérgicas/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Estreptozocina/administración & dosificación , Telocitos/metabolismo
5.
Eur J Pharmacol ; 868: 172851, 2020 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-31836535

RESUMEN

Nicotinic acetylcholine receptor activation on the perivascular sympathetic nerves via axo-axonal interaction mechanism causes norepinephrine release, which triggers the neurogenic nitrergic relaxation in basilar arteries to meet the need of a brain. Donepezil and huperzine A, which are the cholinesterase inhibitors used for Alzheimer's disease therapy, exert controversial effects on nicotinic acetylcholine receptors. Therefore, we investigated how donepezil and huperzine A via the axo-axonal interaction regulate the neurogenic vasodilation of isolated porcine basilar arteries and define their action on different subtypes of the nicotinic acetylcholine receptor by using blood vessel myography, calcium imaging, and electrophysiological techniques. Both nicotine (100 µM) and transmural nerve stimulation (TNS, 8 Hz) induce NO-mediated dilation in the arteries. Nicotine-induced vasodilations were concentration-dependently inhibited by huperzine A and donepezil, with the former being 30 fold less potent than the latter. Both cholinesterase inhibitors weakly and equally decreased TNS-elicited nitrergic vasodilations. Neither huperzine A nor donepezil affected isoproterenol (a ß adrenoceptor-agonist)- or sodium nitroprusside (a NO donor)-induced vasodilation. Further, huperzine A was less potent than donepezil in inhibiting nicotine-elicited calcium influxes in rodent superior cervical ganglionic neurons and inward currents in α7- and α3ß2-nicotinic acetylcholine receptor-expressing Xenopus oocytes. In conclusion, huperzine A may exert less harmful effect over donepezil on maintaining brainstem circulation and on the nicotinic acetylcholine receptor-associated cognition deficits during treatment for Alzheimer's disease.


Asunto(s)
Arteria Basilar/fisiopatología , Inhibidores de la Colinesterasa/efectos adversos , Disfunción Cognitiva/inducido químicamente , Neuronas Nitrérgicas/efectos de los fármacos , Vasodilatación/efectos de los fármacos , Alcaloides/administración & dosificación , Alcaloides/efectos adversos , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/fisiopatología , Animales , Arteria Basilar/efectos de los fármacos , Arteria Basilar/inervación , Tronco Encefálico/irrigación sanguínea , Tronco Encefálico/efectos de los fármacos , Tronco Encefálico/patología , Tronco Encefálico/fisiopatología , Calcio/metabolismo , Inhibidores de la Colinesterasa/administración & dosificación , Disfunción Cognitiva/fisiopatología , Donepezilo/administración & dosificación , Donepezilo/efectos adversos , Relación Dosis-Respuesta a Droga , Humanos , Modelos Animales , Nicotina/metabolismo , Neuronas Nitrérgicas/metabolismo , Neuronas Nitrérgicas/fisiología , Oocitos , Técnicas de Placa-Clamp , Ratas , Receptores Nicotínicos/metabolismo , Sesquiterpenos/administración & dosificación , Sesquiterpenos/efectos adversos , Porcinos , Transmisión Sináptica/efectos de los fármacos , Vasodilatación/fisiología , Xenopus laevis
6.
J Ethnopharmacol ; 244: 112140, 2019 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-31400506

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Perivascular neuropathy was reported to involve in the vascular disorders associated with diabetes. The dried rhizomes of Coptis chinensis Franch. (Latin name: Coptidis Rhizoma; common name: Huang Lian in China), used frequently in Traditional Chinese medicine to treat diabetes (Xiaoke), have been confirmed to possess beneficial effects on diabetic peripheral neuropathy by modern clinical and pharmacological studies. Berberine (BBR), the main effective component of Huang Lian in the treatment of diabetes, is reported to ameliorate diabetic central and peripheral neuropathy. However, the effects of BBR on nerve function of mesenteric and iliac arteries are unclear. AIM OF THE STUDY: To investigate the effects of BBR on the diabetes-induced changes in nitrergic and adrenergic function in mesenteric and iliac arteries. MATERIALS AND METHODS: In this study, the animals were randomized into three groups: control rats, diabetic rats, and diabetic rats gavaged with BBR. We established diabetic rat model using intraperitoneal injection of streptozotocin (STZ, 55 mg kg-1). Two weeks after model establishment, those in the BBR-treated groups were gavaged with berberine chloride (Sichuan Xieli Fharmaceutical. Co., Ltd; 200 mg·kg-1·day-1) diluted in distilled water for another 2 weeks. The superior mesenteric artery and iliac artery were excised. Electric field stimulation (EFS) was used to induce arterial vasoconstriction and explore (1) the diabetes-induced changes in neurogenic function of the superior mesenteric artery and iliac artery; (2) the effects of BBR on neurovascular dysfunction in the early stage of STZ-induced diabetic rats. Nitric oxide (NO) and noradrenaline (NA) released from the nitrergic and adrenergic nerves were quantified using fluorescence assays and ELISA, respectively. RESULTS: EFS induced frequency-dependent vasoconstrictions in both superior mesenteric and iliac artery, and the contractile responses of arteries were abolished by 0.1 µmol·L-1 tetrodotoxin (TTX), or inhibited by 1 µmol·L-1 phentolamine or increased by 0.1 mmol·L-1 Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME). In superior mesenteric artery, but not in iliac artery, the changes of contractile responses with L-NAME were significantly decreased in diabetic rats, and NO release was less also. In contrast, in iliac artery of diabetic rats, but not in superior mesenteric artery, the changes of contractile responses with phentolamine were increased, and NA release was increased significantly. All these changes in diabetic rats on both superior mesenteric artery and iliac artery were reversed by treated with BBR. CONCLUSIONS: In the STZ-induced early diabetic rats, neural control of mesenteric and iliac vasomotor tone are altered differently. The diminished nitrergic nerve in superior mesenteric artery and enhanced adrenergic nerve in iliac artery both contributed to increased vasocontrictor responses. All these changes in diabetic rats were reversed by BBR, suggesting a novel mechanism of BBR in balance of neural regulation of vascular tone.


Asunto(s)
Neuronas Adrenérgicas/efectos de los fármacos , Berberina/farmacología , Diabetes Mellitus Experimental/fisiopatología , Arteria Ilíaca/efectos de los fármacos , Arterias Mesentéricas/efectos de los fármacos , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Adrenérgicas/fisiología , Animales , Diabetes Mellitus Experimental/metabolismo , Arteria Ilíaca/inervación , Arteria Ilíaca/fisiología , Masculino , Arterias Mesentéricas/inervación , Arterias Mesentéricas/fisiología , Neuronas Nitrérgicas/fisiología , Óxido Nítrico/metabolismo , Norepinefrina/metabolismo , Ratas Sprague-Dawley
7.
Am J Physiol Gastrointest Liver Physiol ; 317(2): G210-G221, 2019 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-31268770

RESUMEN

The enteric nervous system in the large intestine generates two important patterns relating to motility: 1) propagating rhythmic peristaltic smooth muscle contractions referred to as colonic migrating motor complexes (CMMCs) and 2) tonic inhibition, during which colonic smooth muscle contractions are suppressed. The precise neurobiological substrates underlying each of these patterns are unclear. Using transgenic animals expressing the genetically encoded calcium indicator GCaMP3 to monitor activity or the optogenetic actuator channelrhodopsin (ChR2) to drive activity in defined enteric neuronal subpopulations, we provide evidence that cholinergic and nitrergic neurons play significant roles in mediating CMMCs and tonic inhibition, respectively. Nitrergic neurons [neuronal nitric oxide synthase (nNOS)-positive neurons] expressing GCaMP3 exhibited higher levels of activity during periods of tonic inhibition than during CMMCs. Consistent with these findings, optogenetic activation of ChR2 in nitrergic neurons depressed ongoing CMMCs. Conversely, cholinergic neurons [choline acetyltransferase (ChAT)-positive neurons] expressing GCaMP3 markedly increased their activity during the CMMC. Treatment with the NO synthesis inhibitor Nω-nitro-l-arginine also augmented the activity of ChAT-GCaMP3 neurons, suggesting that the reciprocal patterns of activity exhibited by nitrergic and cholinergic enteric neurons during distinct phases of colonic motility may be related.NEW & NOTEWORTHY Correlating the activity of neuronal populations in the myenteric plexus to distinct periods of gastrointestinal motility is complicated by the difficulty of measuring the activity of specific neuronal subtypes. Here, using mice expressing genetically encoded calcium indicators or the optical actuator channelrhodopsin-2, we provide compelling evidence that cholinergic and nitrergic neurons play important roles in mediating coordinated propagating peristaltic contractions or tonic inhibition, respectively, in the murine colon.


Asunto(s)
Neuronas Colinérgicas , Colon , Neuronas Nitrérgicas , Nitroarginina/farmacología , Peristaltismo , Animales , Animales Modificados Genéticamente , Neuronas Colinérgicas/efectos de los fármacos , Neuronas Colinérgicas/fisiología , Colon/inervación , Colon/fisiología , Sistema Nervioso Entérico/efectos de los fármacos , Sistema Nervioso Entérico/fisiología , Inhibidores Enzimáticos/farmacología , Ratones , Contracción Muscular/efectos de los fármacos , Contracción Muscular/fisiología , Complejo Mioeléctrico Migratorio/efectos de los fármacos , Complejo Mioeléctrico Migratorio/fisiología , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/fisiología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Optogenética , Peristaltismo/efectos de los fármacos , Peristaltismo/fisiología
8.
Behav Brain Res ; 364: 85-98, 2019 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-30738102

RESUMEN

The present study was designed to investigate the effect of ascorbic acid (AA) treatment on the anxiety related behavioral and neurochemical alterations. AA (50, 100 and 200 mg/kg, i.p.) was administered to the mice and anxiety related behavior and levels of glutamate and nitrite in the brain of mice were determined. The results obtained revealed that the administration of AA (100 mg/kg, i.p.) significantly reduced the anxiety related behavior and the levels of nitrite in the brain of mice. Nitrergic interactions were further determined by the pretreatment of mice with nitric oxide (NO) modulator and AA treatment followed by behavioral and neurochemical measurements. The results obtained suggested that NO inhibition potentiated the anxiolytic like activity of AA in mice. It was also observed that the glutamate and nitrite level in the brain of mice were significantly reduced by the NO inhibitor pretreatment. Thus, the present study demonstrated the possible nitrergic pathways modulation in the anxiolytic like activity of AA in mice.


Asunto(s)
Ansiolíticos/metabolismo , Ansiedad/metabolismo , Ácido Ascórbico/farmacología , Afecto/efectos de los fármacos , Animales , Ansiedad/inducido químicamente , Trastornos de Ansiedad/metabolismo , Conducta Animal/fisiología , Encéfalo/metabolismo , Modelos Animales de Enfermedad , Ácido Glutámico/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Actividad Motora/efectos de los fármacos , Nitratos/metabolismo , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/metabolismo , Óxido Nítrico/metabolismo , Transducción de Señal/efectos de los fármacos
9.
Br J Pharmacol ; 175(19): 3773-3783, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30007000

RESUMEN

BACKGROUND AND PURPOSE: The aim of the present study was to assess the interaction of nitrergic neurotransmission within the bed nucleus of the stria terminalis (BNST) with local glutamatergic and noradrenergic neurotransmission in the control of cardiovascular responses to acute restraint stress in rats. EXPERIMENTAL APPROACH: Interaction with local noradrenergic neurotransmission was evaluated using local pretreatment with the selective α1 -adrenoceptor antagonist WB4101 before microinjection of the NO donor NOC-9 into the BNST. Interaction with glutamatergic neurotransmission was assessed by pretreating the BNST with a selective inhibitor of neuronal NOS (nNOS), Nω-propyl-L-arginine (NPLA) before local microinjection of NMDA. The effect of intra-BNST NPLA microinjection in animals locally pretreated with WB4101 was also evaluated. KEY RESULTS: NOC-9 reduced the heart rate (HR) and blood pressure increases evoked by restraint stress. These effects of NOC-9 on HR, but not in blood pressure, was inhibited by pretreatment of BNST with WB4101. NMDA enhanced the restraint-evoked HR increase, and this effect was abolished following BNST pretreatment with NPLA. Administration of NPLA to the BNST of animals pretreated locally with WB4101 decreased the HR and blood pressure increases induced by restraint. CONCLUSION AND IMPLICATIONS: These results indicate that inhibitory control of stress-evoked cardiovascular responses by nitrergic signalling in the BNST is mediated by a facilitation of local noradrenergic neurotransmission. The present data also provide evidence of an involvement of local nNOS in facilitatory control of tachycardia during stress by NMDA receptors within the BNST.


Asunto(s)
Sistema Cardiovascular/metabolismo , Neuronas Nitrérgicas/metabolismo , Núcleos Septales/metabolismo , Estrés Psicológico/metabolismo , Animales , Sistema Cardiovascular/efectos de los fármacos , Dioxanos/administración & dosificación , Dioxanos/farmacología , Masculino , Neuronas Nitrérgicas/efectos de los fármacos , Ratas , Ratas Wistar , Núcleos Septales/efectos de los fármacos , Estrés Psicológico/tratamiento farmacológico , Transmisión Sináptica/efectos de los fármacos
10.
Vascul Pharmacol ; 108: 36-45, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29751093

RESUMEN

We aimed to determine the influence of nitrergic innervation function on the decreased mesenteric arterial tone induced by high levels of triiodothyronine (T3), as a model of acute thyroiditis, as well as the mechanism/s implicated. We analysed in mesenteric segments from male Wistar rats the effect of 10 nmol/L T3 (2 h) on the vasomotor response to electrical field stimulation (EFS) in the presence/absence of specific neuronal NOS (nNOS) inhibitor L-NPA, or superoxide anion scavenger tempol. Nitric oxide (NO) release was measured in the presence/absence of tempol or PI3K inhibitor LY294002. Superoxide anion and peroxynitrite releases, nNOS, PI3K, AKT and superoxide dismutase (SOD) 1 and 2 expressions, nNOS and AKT phosphorylation, and SOD activity were analysed. T3 decreased EFS-induced vasoconstriction. L-NPA increased EFS-induced vasoconstriction more markedly in T3-incubated segments. T3 increased NO release. Tempol decreased EFS-induced vasoconstriction and augmented NO release only in segments without T3. LY294002 decreased NO release in T3-incubated segments. T3 diminished superoxide anion and peroxynitrite formation, enhanced SOD-2 expression, nNOS and AKT phosphorylations and SOD activity, and did not modify nNOS, PI3K, AKT and SOD-1 expressions. In conclusion, these results show a compensatory mechanism aimed at reducing the enhanced blood pressure that appears during acute thyroiditis.


Asunto(s)
Arterias Mesentéricas/inervación , Neuronas Nitrérgicas/efectos de los fármacos , Óxido Nítrico/metabolismo , Fosfatidilinositol 3-Quinasa/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Triyodotironina/farmacología , Vasoconstricción/efectos de los fármacos , Vasodilatación/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Inhibidores Enzimáticos/farmacología , Depuradores de Radicales Libres/farmacología , Técnicas In Vitro , Masculino , Neuronas Nitrérgicas/enzimología , Óxido Nítrico Sintasa de Tipo I/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo I/metabolismo , Estrés Nitrosativo/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Ácido Peroxinitroso/metabolismo , Fosforilación , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Superóxidos/metabolismo , Factores de Tiempo
11.
Sci Rep ; 8(1): 5923, 2018 04 12.
Artículo en Inglés | MEDLINE | ID: mdl-29651005

RESUMEN

Toll-like receptors (TLRs) are expressed in enteric neurons, glia, gastrointestinal (GI) smooth muscle and mucosa, yet their functional roles in the GI tract are not fully understood. TLRs have been linked to many of the undesirable central effects of chronic opioid administration including hyperalgesia and dependence via activation of central microglia. Opioid-induced bowel dysfunction (OIBD) remains a primary reason for the reduction or withdrawal of opioid analgesics. Morphine-induced inhibition of colonic motility was assessed in vivo by GI transit studies and in vitro using isolated colons from wildtype (WT) and TLR deficient mice. Morphine slowed movement of ingested content in WT but this retardation effect was attenuated in TLR4 -/- and TLR2/4 -/- . In isolated colons, morphine reduced amplitude and frequency colonic migrating motor contractions in both WT and TLR2/4 -/- . Electrical field stimulation elicited distal colon relaxation that was potentiated by morphine in WT but not in TLR2/4 -/- . Inhibitory junction potentials were of similar amplitude and kinetics in WT and TLR2/4 -/- distal colon and not altered by morphine. Enteric nerve density and proportion of nitrergic nerves were similar in WT and TLR2/4 -/- distal colon. These data suggest an involvement of TLRs in opioid pharmacodynamics and thus a potential interventional target for OIBD.


Asunto(s)
Analgésicos Opioides/efectos adversos , Tracto Gastrointestinal/fisiopatología , Morfina/efectos adversos , Receptor Toll-Like 2/genética , Receptor Toll-Like 4/genética , Analgésicos Opioides/administración & dosificación , Animales , Colon/efectos de los fármacos , Colon/fisiopatología , Motilidad Gastrointestinal/efectos de los fármacos , Tracto Gastrointestinal/efectos de los fármacos , Tránsito Gastrointestinal/efectos de los fármacos , Tránsito Gastrointestinal/fisiología , Humanos , Ratones , Ratones Noqueados , Microglía/efectos de los fármacos , Microglía/patología , Morfina/administración & dosificación , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Músculo Liso/patología , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/patología
12.
Pharmacol Rep ; 70(3): 426-433, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29626646

RESUMEN

BACKGROUND: Colitis, a colonic inflammatory condition, showed a linkage with hepatobiliary disorders such as cirrhosis. It has been reported that both endogenous opioids and nitric oxide (NO) play critical roles in colitis pathogenesis. Moreover, opioid and NO levels showed elevation in patients with cirrhosis. The aim of this study was to evaluate the effect of cirrhosis on the experimental model of colitis and the possible involvement of opioidergic/nitrergic systems in rats. METHODS: Colitis was induced by acetic acid 28days after bile duct ligation (BDL). L-NAME, as an inhibitor of NO synthase and naltrexone, as an antagonist of opioid receptors were administered intraperitoneally to animals during 3days after induction of colitis. Macroscopic colitis lesion area, inflammatory mediators change, NO metabolite levels, and colon microscopic injuries were assessed 3days after induction. RESULTS: Cirrhosis significantly reduced the severity of damages to the colon. Administration of L-NAME (10mg/kg), naltrexone (10mg/kg) and co-administration of L-NAME (1mg/kg) and naltrexone (5mg/kg) significantly decreased the protective effect of BDL on colitis. Nitrite elevated levels in BDL rats were significantly diminished in L-NAME- and naltrexone-treated animals. Histopathology parameters and cytokines level alterations in the colon of acetic acid-treated animals after BDL was reversed after injection of L-NAME, naltrexone, and co-administration of L-NAME (1mg/kg) + naltrexone (5mg/kg). CONCLUSION: Cirrhosis improved the intestinal damages induced by acetic acid in rats which may be mediated through interaction of nitrergic and opioidergic systems.


Asunto(s)
Ácido Acético/efectos adversos , Conductos Biliares/fisiopatología , Intestinos/efectos de los fármacos , Intestinos/fisiopatología , Cirrosis Hepática/fisiopatología , Neuronas Nitrérgicas/fisiología , Péptidos Opioides/metabolismo , Analgésicos Opioides/farmacología , Animales , Conductos Biliares/metabolismo , Inhibidores Enzimáticos/farmacología , Mucosa Intestinal/metabolismo , Ligadura/métodos , Cirrosis Hepática/metabolismo , Masculino , NG-Nitroarginina Metil Éster/farmacología , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa/metabolismo , Nitritos/farmacología , Ratas , Ratas Wistar , Receptores Opioides/metabolismo
13.
J Sex Med ; 15(4): 480-491, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29550465

RESUMEN

BACKGROUND: Previously, we found that the neuropeptide galanin was strongly upregulated soon after bilateral cavernous nerve injury (BCNI) and that galanin and its receptors were expressed in nitrergic erectile innervation. Galanin has been observed to exert neuroregenerative effects in dorsal root ganglion neurons, but evidence for these effects in the major pelvic ganglion (MPG) after BCNI is lacking. AIM: To evaluate the neurotropic effects of galanin receptor agonists and antagonists in vitro in nitrergic neurons and MPG and in vivo in rats after BCNI. METHODS: Male Sprague-Dawley rats underwent BCNI and sham surgery. Organ culture and single-cell neuron culture of the MPG were performed. Osmotic pump treatment with the galanin agonist in vivo and measurement of erectile response to electrostimulation after BCNI, immunohistochemical localization of galanin and receptors in the human neurovascular bundle, and myographic analysis of rat corpus cavernosum smooth muscle relaxation to galanin receptor agonists were investigated. OUTCOMES: Neurite outgrowth in vitro and erectile response to electrostimulation after BCNI in vivo, immunohistochemical localization of galanin and receptors, and penile muscle relaxation in vitro. RESULTS: Galanin showed neurotrophic action in vitro and inhibition of endogenous galanin significantly impaired neurite outgrowth in nitrergic but not in sympathetic MPG neurons. In vivo administration of a selective galanin receptor-2 agonist, M1145, resulted in partial recovery of erectile function (EF) after BCNI. Galanin did not act as a direct vasodilator on corpus cavernosum muscle strips. CLINICAL TRANSLATION: Endogenous neurotrophins such as galanin could be used as a strategy to improve EF for patients after BCNI from radical prostatectomy. STRENGTHS AND LIMITATIONS: We evaluated the effect of galanin on nerve regeneration and EF recovery in vivo and in vitro. Limitations include the lack of washout period for the in vivo experiment and absence of differences in the expression of neuronal markers between treatment groups. CONCLUSIONS: We identified galanin as a potential endogenous mechanism for nerve regeneration after BCNI, which could play a physiologic role in EF recovery after radical prostatectomy. In vivo treatment with exogenous galanin was beneficial in enhancing EF recovery after BCNI, but further research is necessary to understand the underlying mechanisms. Weyne E, Hannan JL, Gevaert T, et al. Galanin Administration Partially Restores Erectile Function After Cavernous Nerve Injury and Mediates Endogenous Nitrergic Nerve Outgrowth In Vitro. J Sex Med 2018;15:480-491.


Asunto(s)
Disfunción Eréctil/etiología , Galanina/farmacología , Factores de Crecimiento Nervioso/farmacología , Neuronas Nitrérgicas/efectos de los fármacos , Pene/inervación , Traumatismos de los Nervios Periféricos/complicaciones , Animales , Modelos Animales de Enfermedad , Disfunción Eréctil/terapia , Galanina/administración & dosificación , Masculino , Factores de Crecimiento Nervioso/administración & dosificación , Regeneración Nerviosa/efectos de los fármacos , Erección Peniana/efectos de los fármacos , Prostatectomía/efectos adversos , Ratas , Ratas Sprague-Dawley , Receptores de Galanina/agonistas , Recuperación de la Función
14.
Reprod Biol ; 18(1): 83-93, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29402603

RESUMEN

The aim of the study was to examine the toxic effects of Monosodium glutamate (MSG), an extensively used food additive, on the contraction of uterine visceral smooth muscle (UVSM) in rat and to elucidate the probable neurocrine mechanism involved in it. MSG produced significant potentiation of the force and inhibition of frequency of uterus recorded ex vivo in chronic MSG exposure and in single dose acute experiments. MSG also produced significant potentiation of force of acetylcholine induced contraction and no alterations in atropine induced contraction of uterus. Further, MSG produced significant increase in force and frequency of contraction of neostigmine incubated uterus. We have found significant potentiation of the post pause force of contraction of uterus when MSG was applied in adrenaline incubated uterus. MSG also produced significant decrease in frequency of contraction of sodium nitroprusside incubated uterus; increase in frequency of N-ω-Nitro-l-Arginine Methyl Ester incubated uterus and no significant changes in frequency of contraction of methylene blue incubated uterus. These results indicate that MSG potentiates the force of contraction of UVSM predominantly by augmenting the activity of cholinergic intrinsic efferents and inhibits the frequency of contraction probably by augmenting the activity of nitrergic efferents. In conclusion, MSG potentiates the force and inhibits the frequency of contraction of UVSM, and the MSG induced effect is probably mediated through the augmentation of acetylcholine and nitric oxide signaling pathways.


Asunto(s)
Acetilcolina/agonistas , Aromatizantes/efectos adversos , Miometrio/fisiología , Óxido Nítrico/agonistas , Sistemas de Mensajero Secundario , Glutamato de Sodio/efectos adversos , Contracción Uterina , Acetilcolina/antagonistas & inhibidores , Acetilcolina/metabolismo , Agonistas Adrenérgicos/farmacología , Animales , Inhibidores de la Colinesterasa/farmacología , Inhibidores Enzimáticos/farmacología , Femenino , Antagonistas Muscarínicos/farmacología , Miometrio/efectos de los fármacos , Miometrio/inervación , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/fisiología , Óxido Nítrico/antagonistas & inhibidores , Óxido Nítrico/metabolismo , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Distribución Aleatoria , Ratas , Sistemas de Mensajero Secundario/efectos de los fármacos , Pruebas de Toxicidad Aguda , Pruebas de Toxicidad Crónica , Contracción Uterina/efectos de los fármacos
15.
Int J Mol Sci ; 18(10)2017 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-29036889

RESUMEN

Neuropathic pain is a severe condition with unsatisfactory treatments. Melatonin, an indolamine, seems to be a promising molecule suitable for this purpose due to its well-known anti-inflammatory, analgesic, and antioxidant effects, as well as its modulation of the nitroxidergic system. Nevertheless, the data on its mechanism of action and potentialities are currently insufficient in this pathology, especially at the peripheral level. Thus, this work evaluated the effect of a single administration of melatonin in an established mononeuropathy pain model that monitors the behaviour and the changes in the nitroxidergic system in dorsal root ganglia and skin, which are affected by nervous impairment. Experiments were carried out on Sprague Dawley rats subdivided into the sham operated (control) and the chronic constriction injured animals, a model of peripheral neuropathic pain on sciatic nerve. Single administrations of melatonin (5-10 mg/kg) or vehicle were injected intraperitoneally on the 14th day after surgery, when the mononeuropathy was established. The animals were behaviourally tested for thermal hyperalgesia. The dorsal root ganglia and the plantar skin of the hind-paws were removed and processed for the immunohistochemical detection of neuronal and inducible nitric oxide synthases. The behavioural results showed an increase of withdrawal latency during the plantar test as early as 30 min after melatonin administration. The immunohistochemical results indicated a modulation of the nitroxidergic system both at dorsal root ganglia and skin level, permitting speculate on a possible mechanism of action. We showed that melatonin may be a possible therapeutic strategy in neuropathic pain.


Asunto(s)
Hiperalgesia/metabolismo , Hiperalgesia/fisiopatología , Melatonina/administración & dosificación , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/metabolismo , Nervios Periféricos/efectos de los fármacos , Nervios Periféricos/fisiopatología , Animales , Modelos Animales de Enfermedad , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/metabolismo , Ganglios Espinales/fisiopatología , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/etiología , Inmunohistoquímica , Masculino , Neuralgia/tratamiento farmacológico , Neuralgia/etiología , Neuralgia/metabolismo , Neuralgia/fisiopatología , Óxido Nítrico Sintasa de Tipo I/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Nervios Periféricos/metabolismo , Ratas
16.
J Physiol Biochem ; 73(1): 77-87, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27738973

RESUMEN

Urinary bladder function consists in the storage and controlled voiding of urine. Translational studies require animal models that match human characteristics, such as Octodon degus, a diurnal rodent. This study aims to characterize the contractility of the detrusor muscle and the morphology and code of the vesical plexus from O. degus. Body temperature was measured by an intra-abdominal sensor, the contractility of detrusor strips was evaluated by isometric tension recording, and the vesical plexus was studied by electrical field stimulation (EFS) and immunofluorescence. The animals showed a diurnal chronotype as judged from core temperature. The myogenic contractile response of the detrusor muscle to increasing doses of KCl reached its maximum (31.04 mN/mm2) at 60 mM. In the case of cumulative dose-response of bethanecol, the maximum response (37.42 mN/mm2) was reached at 3.2 × 10-4 M. The response to ATP was clearly smaller (3.8 mN/mm2). The pharmacological dissection of the EFS-induced contraction identified ACh and sensory fibers as the main contributors to this response. The neurons of the vesical plexus were located mainly in the trigone area, grouped in big and small ganglia. Out of them, 48.1 % of the neurons were nitrergic and 62.7 % cholinergic. Our results show functional and morphological similarities between the urinary bladder of O. degus and that of humans.


Asunto(s)
Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Músculo Liso/inervación , Octodon/fisiología , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/inervación , Adenosina Trifosfato/metabolismo , Animales , Betanecol/farmacología , Temperatura Corporal , Neuronas Colinérgicas/citología , Neuronas Colinérgicas/efectos de los fármacos , Neuronas Colinérgicas/metabolismo , Neuronas Colinérgicas/fisiología , Estimulación Eléctrica , Técnica del Anticuerpo Fluorescente Indirecta , Ganglios/anatomía & histología , Ganglios/efectos de los fármacos , Ganglios/metabolismo , Ganglios/fisiología , Humanos , Técnicas In Vitro , Masculino , Agonistas Muscarínicos/farmacología , Músculo Liso/metabolismo , Músculo Liso/fisiología , Natriuréticos/farmacología , Neuronas Nitrérgicas/citología , Neuronas Nitrérgicas/efectos de los fármacos , Neuronas Nitrérgicas/metabolismo , Neuronas Nitrérgicas/fisiología , Octodon/anatomía & histología , Cloruro de Potasio/farmacología , Especificidad de la Especie , Vejiga Urinaria/metabolismo , Vejiga Urinaria/fisiología
17.
Dis Esophagus ; 30(2): 1-8, 2017 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-26725535

RESUMEN

The consequences of using aspirin (ASA) for the pathogenesis of Chagas disease are unclear. This study evaluated the effects of treatment of Chagas disease with ASA on the esophageal nitrergic myenteric neuron population and esophageal wall in mice. We observed that treatment of chagasic infection with ASA protects the esophageal myenteric neurons from the atrophy caused by the Trypanosoma cruzi infection. The mice were infected with 1300 trypomastigotes of Y strain T. cruzi intraperitoneally. Part of infected mice was treated with ASA from fifth to twelfth day after inoculation. Our data support the hypothesis that eicosanoids given during the acute phase of the chagasic infection may act as immunomodulators aiding the transition to and maintenance of the chronic phase of the disease. Besides, ASA treatment did not provoke alterations in the esophageal wall and the myenteric neurons in infected mice.


Asunto(s)
Aspirina/farmacología , Enfermedad de Chagas/tratamiento farmacológico , Inhibidores de la Ciclooxigenasa/farmacología , Esófago/inervación , Plexo Mientérico/efectos de los fármacos , Neuronas Nitrérgicas/efectos de los fármacos , Animales , Atrofia/prevención & control , Enfermedad de Chagas/parasitología , Enfermedad Crónica , Modelos Animales de Enfermedad , Masculino , Ratones , Plexo Mientérico/patología , Neuronas Nitrérgicas/patología , Resultado del Tratamiento , Trypanosoma cruzi/efectos de los fármacos
18.
Pharmacol Rep ; 68(6): 1350-1357, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27710864

RESUMEN

BACKGROUND: Hydrogen sulfide (H2S) is a gaseous signaling molecule that, similar to nitric oxide (NO), plays an important role as an inhibitor neurotransmitter in the digestive tract. This study aimed to investigate the effect of H2S and to identify neurogenic contraction responses dependent on the electrical field stimulation (EFS) in the isolated lower esophageal sphincters of rabbits. METHODS: An isolated lower esophageal sphincter was placed in an organ bath system and mechanical responses were recorded using a force transducer. The nerve-evoked contractile responses were obtained by EFS. The contractile responses were obtained as biphasic "on" and "off" phases seen at the beginning and end of EFS, respectively. RESULTS: Sodium hydrogen sulfide (NaHS) reduced the EFS-mediated "off" phase and the EFS-mediated non-adrenergic non-cholinergic (NANC) "off" phase. NaHS reduced the EFS-mediated "on" phase as well. l-Cysteine ​​reduced the EFS-mediated "off" phase and the EFS-mediated NANC "off" phase. l-Propargylglycine (PAG) did not affect the EFS-mediated "off" phase or the EFS-mediated NANC "off" phase. NaHS, l-cysteine, and PAG reduced the EFS-mediated, NO-independent "off" phase. The effect of NaHS in all of the experiments returned in time. Also, NaHS caused significant relaxation of 80-mM KCl-Krebs solution induced-contractions, while l-cysteine ​​and PAG did not cause a significant relaxation. CONCLUSION: These findings suggest that H2S has an inhibitory effect on the lower esophageal sphincter muscle. While the effect of H2S on EFS-mediated responses disappeared in time, the effect of H2S sustained the KCl-Krebs solution-induced contractions. This shows that H2S may have an effect on neurotransmission at the nerve terminal.


Asunto(s)
Neuronas Adrenérgicas , Neuronas Colinérgicas , Esfínter Esofágico Inferior/efectos de los fármacos , Sulfuro de Hidrógeno/farmacología , Contracción Muscular/efectos de los fármacos , Neuronas Nitrérgicas/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica/métodos , Esfínter Esofágico Inferior/metabolismo , Contracción Muscular/fisiología , Relajación Muscular/efectos de los fármacos , Relajación Muscular/fisiología , Neuronas Nitrérgicas/fisiología , Técnicas de Cultivo de Órganos , Conejos , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología
19.
Neurogastroenterol Motil ; 28(12): 1815-1823, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27302181

RESUMEN

BACKGROUND: Oxytocin (OT) reduces rat duodenal tone and mouse intestinal transit; however, the underlying mechanisms are not totally understood. Consequently, this study was designed to investigate the influence of OT on spontaneous mechanical activity and neurally evoked responses, to characterize the mechanisms of the action, and to determine the distribution of the OT receptor (OTR) in rat proximal colonic muscle strips. METHODS: The organ bath technique with electrical field stimulation, western blotting, and immunofluorescence were used. KEY RESULTS: In rat proximal colon, exogenous OT induced a concentration-dependent reduction of the spontaneous mechanical activity without affecting the resting basal tone, which was abolished by atosiban, an OTR antagonist, by tetrodotoxin (TTX), a neural blocker or by Nω-propyl-l-arginine hydrochloride, an inhibitor of neuronal nitric oxide synthase (nNOS). The inhibitory effects of OT were not affected by atropine or the vasoactive intestinal peptide (VIP) receptor antagonist [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP (VIPHyb). Proximal colon responses to electrical field stimulation were characterized by nonadrenergic, noncholinergic (NANC) relaxation, which was followed by an off-contraction. Oxytocin enhanced only NANC relaxation. Oxytocin stimulated spontaneous NO release from the longitudinal muscle myenteric plexus preparation of rat proximal colon. Western blot and immunohistochemistry experiments showing the presence of the OTR in proximal colon, and its co-localization with nNOS established that myenteric nitrergic neurons express OTR. CONCLUSIONS & INFERENCES: The activation of OTR located on nitrergic neurons may negatively modulate colonic spontaneous contraction and enhance electrically evoked NANC relaxation through excitation of NO release.


Asunto(s)
Colon/fisiología , Neuronas Nitrérgicas/fisiología , Óxido Nítrico/fisiología , Oxitocina/fisiología , Receptores de Oxitocina/fisiología , Animales , Colon/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Masculino , Contracción Muscular/efectos de los fármacos , Contracción Muscular/fisiología , Plexo Mientérico/efectos de los fármacos , Plexo Mientérico/fisiología , Inhibición Neural , Neuronas Nitrérgicas/efectos de los fármacos , Técnicas de Cultivo de Órganos , Oxitocina/farmacología , Ratas , Ratas Wistar , Receptores de Oxitocina/agonistas
20.
Am J Physiol Heart Circ Physiol ; 310(9): H1097-106, 2016 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-26945078

RESUMEN

The diverse signaling events following mitochondrial depolarization in neurons are not clear. We examined for the first time the effects of mitochondrial depolarization on mitochondrial function, intracellular calcium, neuronal nitric oxide synthase (nNOS) activation, and nitric oxide (NO) production in cultured neurons and perivascular nerves. Cultured rat primary cortical neurons were studied on 7-10 days in vitro, and endothelium-denuded cerebral arteries of adult Sprague-Dawley rats were studied ex vivo. Diazoxide and BMS-191095 (BMS), activators of mitochondrial KATP channels, depolarized mitochondria in cultured neurons and increased cytosolic calcium levels. However, the mitochondrial oxygen consumption rate was unaffected by mitochondrial depolarization. In addition, diazoxide and BMS not only increased the nNOS phosphorylation at positive regulatory serine 1417 but also decreased nNOS phosphorylation at negative regulatory serine 847. Furthermore, diazoxide and BMS increased NO production in cultured neurons measured with both fluorescence microscopy and electron spin resonance spectroscopy, which was sensitive to inhibition by the selective nNOS inhibitor 7-nitroindazole (7-NI). Diazoxide also protected cultured neurons against oxygen-glucose deprivation, which was blocked by NOS inhibition and rescued by NO donors. Finally, BMS induced vasodilation of endothelium denuded, freshly isolated cerebral arteries that was diminished by 7-NI and tetrodotoxin. Thus pharmacological depolarization of mitochondria promotes activation of nNOS leading to generation of NO in cultured neurons and endothelium-denuded arteries. Mitochondrial-induced NO production leads to increased cellular resistance to lethal stress by cultured neurons and to vasodilation of denuded cerebral arteries.


Asunto(s)
Arterias Cerebrales/metabolismo , Potencial de la Membrana Mitocondrial , Mitocondrias/enzimología , Neuronas Nitrérgicas/enzimología , Óxido Nítrico Sintasa de Tipo I/metabolismo , Óxido Nítrico/metabolismo , Comunicación Paracrina , Vasodilatación , Animales , Benzopiranos/farmacología , Células Cultivadas , Arterias Cerebrales/efectos de los fármacos , Arterias Cerebrales/inervación , Diazóxido/farmacología , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Imidazoles/farmacología , Indazoles/farmacología , Masculino , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Neuronas Nitrérgicas/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo I/antagonistas & inhibidores , Comunicación Paracrina/efectos de los fármacos , Fosforilación , Canales de Potasio/agonistas , Canales de Potasio/metabolismo , Cultivo Primario de Células , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo , Serina , Transducción de Señal , Vasodilatación/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA